Headquarters
Boston, MAFounded
2018CEO / Founder
Wardah InamEmployees
51-200Funding
Series C — $133MProducts
1 product listedAvg. AI Score
8.0/10Website
overjet.com/Profile updated
Overjet, Inc. develops artificial-intelligence software for the dental industry, using computer vision to analyze dental X-rays and quantify conditions such as decay and bone loss to support diagnosis and treatment planning. The company was founded in 2018 by Wardah Inam, Alexander Jelicich, and Deepak Ramaswamy, who met through MIT and Harvard, and is headquartered in Boston, Massachusetts.
Overjet's platform includes Vision AI, an FDA-cleared tool for radiographic analysis; IRIS imaging software; a Voice AI suite for clinical documentation; and automated insurance-verification and analytics products aimed at dental practices, dental support organizations (DSOs), and payers. Its customers include large DSOs such as Dental Care Alliance, Jefferson Dental & Orthodontics, and Dental365, and the company works with insurers covering more than 120 million members, including several of the largest U.S. dental payers.
Overjet has raised roughly $133 million across several rounds. In March 2024 it closed a $53.2 million Series C led by March Capital, with participation from General Catalyst, Insight Partners, Crosslink Capital, MIT's E14 Fund, and the American Dental Association, valuing the company at about $550 million. Led by co-founder and chief executive Wardah Inam, Overjet employs roughly 180 people and has described its Series C as the largest funding round to date in dental AI.
Dated, source-cited figures. Estimates are marked.
All products by Overjet reviewed by our AI panel of experts.
Six independent reviewer personalities assessed Overjet's product on their own terms. They landed within 0.8 points of each other, an unusually strong consensus.
Averaged across 1 reviewed product in our catalog. Scores are out of 10.
Who Overjet competes with, and how they differ.
Pearl matches Overjet's FDA-cleared dental radiograph AI but claims broader regulatory coverage (26+ clearances across 2D X-ray and 3D CBCT vs. Overjet's 10 FDA clearances) and extends further into DSO practice management with RCM claims automation, ambient voice documentation (Pearl Voice), and clinician training tools.
VideaHealth is Overjet's closest same-city rival — also Boston-based and DSO-first, with pathology-detection AI live across large chains like Aspen Dental (1,100+ practices) and Great Expressions Dental Centers — but younger (launched 2022) and smaller, having raised a $40M Series B in January 2025 versus Overjet's $550M Series C valuation.
Key milestones in Overjet's history, with sources.
FDA clears CBCT Assist, Overjet's 10th clearance
Overjet CBCT Assist received FDA 510(k) clearance to support review and interpretation of 3D cone beam CT scans, the company's 10th FDA clearance to date, according to CEO Wardah Inam.
overjet.comNew equity financing — $24.6M per SEC filing
Overjet sold $24.56M of a $34.8M equity offering, per an SEC Form D filing (dated first sale December 12, 2025) covering 22 investors; no press release or round name accompanied the filing.
sec.govLaunches Dental Clarity Network with MetLife, Humana, Guardian
Overjet launched the Dental Clarity Network, a payer-provider group including MetLife, Humana, Guardian, Dental Care Alliance, and other DSOs, debuting ReviewPASS to let providers skip manual insurance review for many procedures.
healthcaredive.comFDA clears AI image enhancement, an industry first
Overjet received FDA clearance for AI-powered image enhancement that automatically improves blurry or noisy dental X-rays, becoming the first and only dental AI platform FDA-cleared to enhance images.
overjet.comSeries C — $53.2M led by March Capital at $550M valuation
Overjet raised $53.2M in Series C financing led by March Capital, with the American Dental Association participating, reaching a $550M valuation and bringing total funding to approximately $133M — described as the largest single investment in dental AI history.
prnewswire.comFDA clears Caries Assist, Overjet's second clearance
Overjet Caries Assist received FDA 510(k) clearance as AI-powered caries detection and outlining software; in testing it helped dentists detect 32% more tooth surfaces containing decay.
prnewswire.comSeries B — $42.5M at $425M valuation
Overjet raised $42.5M in Series B financing led by General Catalyst and Insight Partners, with Crosslink Capital and E14 Fund participating, reaching a $425M valuation and bringing total funding to nearly $80M.
prnewswire.comSeries A — $27M led by General Catalyst and Insight Partners
Overjet raised $27M in Series A financing led by General Catalyst and Insight Partners, with Crosslink Capital and E14 Fund participating, as the company became the leading dental AI vendor to insurers covering over 53 million Americans.
prnewswire.comFDA clears Dental Assist, a dental AI industry first
Overjet Dental Assist received FDA 510(k) clearance to measure periodontal bone levels on radiographs, making Overjet the first dental AI company cleared by the FDA to sell directly to dental practices, with accuracy comparable to experienced dentists.
prnewswire.comSeed round — $7.85M led by Crosslink Capital
Overjet raised $7.85M in seed funding led by Crosslink Capital, with participation from the MIT-affiliated E14 Fund, to build its dental radiograph AI.
finance.yahoo.comFounded in Boston by Wardah Inam
Overjet was founded in Boston in 2018 when MIT computer scientists, including CEO Wardah Inam (PhD, electrical engineering and computer science), partnered with Harvard-affiliated dentists at Harvard Innovation Labs to build AI for reading dental X-rays.
forbes.comBrowse multi-perspective AI panel reviews across hundreds of AI tools, agents, and platforms. Find the right software with insights from CTO, Developer, Marketer, Finance, and User perspectives.